What liver enzyme tests should be monitored in extended tigecycline use?

In prolonged (extended) tigecycline therapy, it’s important to monitor liver function tests, especially because tigecycline can cause hepatotoxicity and cholestatic or mixed liver enzyme elevations.

Liver enzyme tests to monitor

Commonly monitored labs include:

• ALT (alanine aminotransferase)
• AST (aspartate aminotransferase)
• Alkaline phosphatase (ALP)
• Total bilirubin (often also direct bilirubin, if available)

Also consider (often part of liver monitoring)

• Albumin (baseline and trending can help if therapy is long)
• INR / PT (if there are signs of significant hepatic dysfunction)

Practical monitoring approach (typical)

• Get baseline LFTs before starting, then
• Trend periodically during therapy (frequency depends on risk factors, prior liver disease, and how abnormal baseline values are—many clinicians monitor at least weekly in extended courses, or more often if abnormalities appear).

Stop/hold considerations

If you share the exact regimen and your patient’s baseline labs/risk factors, I can help interpret what changes are usually concerning. In general, clinicians look for rising transaminases, worsening bilirubin, and especially any combination suggesting clinically significant liver injury.

If you tell me the setting (adult vs pediatric, ICU vs inpatient, duration planned, and any baseline liver abnormalities), I can suggest a more tailored monitoring frequency and thresholds to discuss with the treating team.